I would think Tekcyte's tech would be worth well north of $230k the question is how much?Not to me it isn't. When someone pulls a number out of nowhere and then says the question is something else - I think that isn't the actual question. I think the question is their objectivity.
We don't have a skin wound application yet - (that only happens after effectiveness is demonstrated to an objective standard as a minimum and then the regulators approve) we don't have even the results of the first phase 1 trial.
I don't have the patience to be gentle with fools that have been fools through multiple cash raises at lower points when management is still not accountable, still clueless, still rentseeking and cash is running out faster than results for not sufficiently justified trials are still coming in too slowly.
Pyramid selling not working for you - become a holder in mesenchymal stem cell related ASX companies and pump like you haven't sold your soul and aren't actually an impediment to the development of good medicines with your uncritical greed.
- Forums
- ASX - By Stock
- CYP
- Ann: Cleansing Notice
Ann: Cleansing Notice, page-5
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.48M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.5¢ | $11.47K | 50.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 66554 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 56020 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 66554 | 0.225 |
3 | 106863 | 0.220 |
3 | 60813 | 0.215 |
3 | 76250 | 0.210 |
2 | 51780 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 56020 | 4 |
0.240 | 60000 | 2 |
0.250 | 19770 | 2 |
0.270 | 85000 | 2 |
0.275 | 30000 | 1 |
Last trade - 13.05pm 13/11/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online